AFDN and metabolic dysfunction-associated steatohepatitis: Together, these results indicated that AF6 promotes inflammation and cell death in most liver diseases, including acute liver injury, non-alcoholic steatohepatitis (NASH) and the systemic inflammatory response syndrome (SIRS).